Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient
Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory illness caused by SARS-CoV-2. Not much is yet known about this new viral disease. In our early encounter with the COVID-19, before the pandemic and during the early days of dealing with this novel viral disease in our country, we...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Otolaryngology |
| Online Access: | http://dx.doi.org/10.1155/2020/5892047 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832547638027747328 |
|---|---|
| author | Sam K. Touisserkani Azin Ayatollahi |
| author_facet | Sam K. Touisserkani Azin Ayatollahi |
| author_sort | Sam K. Touisserkani |
| collection | DOAJ |
| description | Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory illness caused by SARS-CoV-2. Not much is yet known about this new viral disease. In our early encounter with the COVID-19, before the pandemic and during the early days of dealing with this novel viral disease in our country, we saw some cases of anosmia in patients infected by SARS-CoV-2. In many cases, this chemosensitive dysfunction persisted after the negativization of the nasopharyngeal swab. We report effective treatment of anosmia by oral corticosteroid therapy in a patient recovered from COVID-19. |
| format | Article |
| id | doaj-art-5b60f77f0bd44b019c0989834ff71d64 |
| institution | Kabale University |
| issn | 2090-6765 2090-6773 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Otolaryngology |
| spelling | doaj-art-5b60f77f0bd44b019c0989834ff71d642025-02-03T06:43:59ZengWileyCase Reports in Otolaryngology2090-67652090-67732020-01-01202010.1155/2020/58920475892047Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old PatientSam K. Touisserkani0Azin Ayatollahi1Private Office, Tehran, IranTehran University of Medical Sciences, Center for Research and Training in Skin Diseases and Leprosy, Tehran, IranCoronavirus disease 2019 (COVID-19) is a highly infectious respiratory illness caused by SARS-CoV-2. Not much is yet known about this new viral disease. In our early encounter with the COVID-19, before the pandemic and during the early days of dealing with this novel viral disease in our country, we saw some cases of anosmia in patients infected by SARS-CoV-2. In many cases, this chemosensitive dysfunction persisted after the negativization of the nasopharyngeal swab. We report effective treatment of anosmia by oral corticosteroid therapy in a patient recovered from COVID-19.http://dx.doi.org/10.1155/2020/5892047 |
| spellingShingle | Sam K. Touisserkani Azin Ayatollahi Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient Case Reports in Otolaryngology |
| title | Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient |
| title_full | Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient |
| title_fullStr | Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient |
| title_full_unstemmed | Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient |
| title_short | Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient |
| title_sort | oral corticosteroid relieves post covid 19 anosmia in a 35 year old patient |
| url | http://dx.doi.org/10.1155/2020/5892047 |
| work_keys_str_mv | AT samktouisserkani oralcorticosteroidrelievespostcovid19anosmiaina35yearoldpatient AT azinayatollahi oralcorticosteroidrelievespostcovid19anosmiaina35yearoldpatient |